Jane L. Meisel, MD
-
RoleMedical Oncology
-
Specialty
-
Research Program
-
Practicing Since2014
Background
Jane Lowe Meisel, MD, is a board-certified medical oncologist with a special interest in women's health and in cancers that affect women, particularly breast cancer. Her goal is to provide compassionate, exceptional, state-of-the-art care to patients and to conduct research that improves treatment options for these patients.
Dr. Meisel is a professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, with a secondary appointment in the Department of Gynecology and Obstetrics. She joined the Glenn Family Breast Center at Winship Cancer Institute as a practicing physician in 2015.
Titles & Roles
-
Professor, Department of Hematology and Medical OncologyEmory University School of Medicine
-
Professor, Department of Gynecology & ObstetricsEmory University School of Medicine
-
Co-Director, Breast Medical Oncology, Department of Hematology and Medical OncologyEmory University School of Medicine
Education & Training
Education
- Fellowship, Medical Oncology, 2014Memorial Sloan Kettering Cancer Center
- Residency, Internal Medicine, 2011Brigham and Women's Hospital
- Medical Education, MD, 2008Harvard Medical School
Board Certifications
- Medical OncologyAmerican Board of Internal Medicine, 2014Internal MedicineAmerican Board of Internal Medicine, 2011
Professional Memberships
Dr. Meisel is a member of the Eastern Cooperative Oncology Group and serves on the Development Therapeutics Committee at NRG Oncology. She also serves as leader of the Professional Development Committee Women in Oncology Work Group and as a member of the Cancer Education Committee at American Society of Clinical Oncology.
Research
Dr. Meisel has presented her research on breast cancer and gynecologic malignancies at national meetings and has published her work in peer-reviewed journals. Her research is focused on the development of new therapeutic options for women with gynecologic and breast cancers, and on improving quality of life for these patients.
Clinical Trials
Dr. Meisel serves as the principal investigator for many therapeutic trials for patients with breast and gynecologic malignancies at Winship Cancer Institute.
-
- PhaseIII
-
ConditionsBreast Cancer
- LocationWinship Cancer Institute
-
-
- PhaseIII
-
ConditionsAnatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
- LocationEmory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Grady Health System, Winship Cancer Institute
-
-
- PhaseIII
-
ConditionsMetastatic Breast Cancer
- LocationEmory University Hospital Midtown, Winship Cancer Institute
-
-
- PhaseII
-
ConditionsHER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer, Node Negative Breast Cancer, Micrometastasis Breast Cancer, Hormone Receptor Positive Breast Cancer
- LocationEmory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute
-
Publications
Title/Journal Authors Publication Date Clinical breast cancer
SB Goldfarb, SL Sammons, JL Meisel, TJ Pluard, SN Jenkins, BS Komm, D Carroll, DJ Portman 04/01/2025 Annals of surgical oncology
ML Fefferman, DM Thompson, LG Wilke, S Hwang, R Bleicher, LM Freedman, JL Meisel, K Kuchta, K Yao 03/01/2025 Annals of surgical oncology
ML Fefferman, DM Thompson, LG Wilke, S Hwang, R Bleicher, LM Freedman, JL Meisel, K Kuchta, K Yao 03/01/2025 JCO oncology practice
AG Waks, EL Chen, N Graham, AM Frey, K Almeida, V Attaya, C Ryding, I Abbass, A Fung, J Sussell, P Cortazar, C Harvey, D Leth, M Faggen, N Sinclair, J Walsh, N Tung, S Sinclair, S Lo, D Yardley, V Valero, J Meisel, TJ Ballinger, S Adams, LA Carey, JK Rauch, VG Abramson, NO Williams, WY Chen, JP Leone, ST Schumer, N Tayob, SM Tolaney 03/01/2025 Scientific reports
V Jones, HH Yin, YC Yuan, Y Wang, SM Li, D Aljaber, A Sanchez, C Quinones, D Schmolze, Y Yuan, J Mortimer, L Yee, L Kruper, T Jovanovic-Talisman, J Tomsic, N Sanchez, T Chavez, RM O'Regan, QJ Khan, M Davis, K Kalinsky, J Meisel, R Kittles, L Rodriguez-Rodriguez, V Seewaldt 02/28/2025 Genomic and transcriptomic landscape of HER2-low breast cancer.
Breast cancer research and treatment
R Bansal, T Adeyelu, A Elliott, P Walker, MA Bustos, E Rodriguez, MK Accordino, J Meisel, ME Gatti-Mays, E Hsu, K Lathrop, V Kaklamani, M Oberley, G Sledge, SL Sammons, SL Graff 01/01/2025 ESMO open
E Agostinetto, G Pfeiler, D Hlauschek, EL Mayer, M Lambertini, E de Azambuja, M Bellet-Ezquerra, JL Meisel, G Rubovszky, N Zdenkowski, Y Novik, M Ruiz-Borrego, KA Gelmon, EP Mamounas, H Iwata, DR Lu, L Soelkner, C Fesl, M Gnant, A DeMichele 01/01/2025 Therapeutic advances in medical oncology
HL McArthur, SM Tolaney, R Dent, P Schmid, J Asselah, Q Liu, JL Meisel, N Niikura, YH Park, G Werutsky, G Bianchini, JC Andersen, R Kozarski, N Rokutanda, B Pistilli, S Loibl 01/01/2025 Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.
JCO precision oncology
R Bansal, T Adeyelu, A Elliott, AR Tan, JR Ribeiro, J Meisel, MJ Oberley, SL Graff, GW Sledge, JE Grilley-Olson, SL Sammons, LH Rosenberger 12/01/2024 Nature medicine
K Khoury, JL Meisel, C Yau, HS Rugo, R Nanda, M Davidian, B Tsiatis, AJ Chien, AM Wallace, M Arora, M Rozenblit, DL Hershman, A Zimmer, AS Clark, H Beckwith, AD Elias, E Stringer-Reasor, JC Boughey, C Nangia, C Vaklavas, C Omene, KS Albain, KM Kalinsky, C Isaacs, J Tseng, ET Roussos Torres, B Thomas, A Thomas, A Sanford, R Balassanian, C Ewing, K Yeung, C Sauder, T Sanft, L Pusztai, MS Trivedi, A Outhaythip, W Li, N Onishi, AL Asare, P Beineke, P Norwood, L Brown-Swigart, GL Hirst, JB Matthews, B Moore, W Fraser Symmans, E Price, C Beedle, J Perlmutter, P Pohlmann, RA Shatsky, A DeMichele, D Yee, LJ van 't Veer, NM Hylton, LJ Esserman 12/01/2024 European journal of nuclear medicine and molecular imaging
A Mushtaq, IO Lawal, S Muzahir, SC Friend, M Bhave, JL Meisel, MA Torres, TM Styblo, CL Graham, K Kalinsky, J Switchenko, GA Ulaner, DM Schuster 11/01/2024 JCO oncology practice
I Graetz, S Hernandez, S Arshad, K Byers, J Meisel, G Sadigh, EA Sakach, K Gogineni, MA Torres 10/01/2024 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
EL Mayer, Y Ren, N Wagle, R Mahtani, C Ma, A DeMichele, M Cristofanilli, J Meisel, KD Miller, Y Abdou, EC Riley, R Qamar, P Sharma, S Reid, N Sinclair, M Faggen, CC Block, N Ko, AH Partridge, WY Chen, M DeMeo, V Attaya, A Okpoebo, J Alberti, Y Liu, E Gauthier, HJ Burstein, MM Regan, SM Tolaney 06/10/2024 Breast cancer research and treatment
SJ Wood, Y Gao, JH Lee, J Chen, Q Wang, JL Meisel, X Li 05/01/2024 Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
X Li, JH Lee, Y Gao, J Zhang, KM Bates, DL Rimm, H Zhang, GH Smith, D Lawson, J Meisel, J Chang, L Huo 02/01/2024 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
G Sadigh, JL Meisel, K Byers, A Robles, L Serrano, OS Jung, D Coleman, KA Yeager, I Graetz 12/01/2023 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
G Pfeiler, D Hlauschek, EL Mayer, C Deutschmann, S Kacerovsky-Strobl, M Martin, JL Meisel, N Zdenkowski, S Loibl, M Balic, H Park, A Prat, C Isaacs, E Bajetta, JM Balko, M Bellet-Ezquerra, J Bliss, H Burstein, F Cardoso, H Fohler, T Foukakis, KA Gelmon, M Goetz, TC Haddad, H Iwata, J Jassem, SC Lee, B Linderholm, M Los, EP Mamounas, KD Miller, PG Morris, E Munzone, EN Gal-Yam, A Ring, L Shepherd, C Singer, C Thomssen, LM Tseng, P Valagussa, EP Winer, AC Wolff, G Zoppoli, J Machacek-Link, C Schurmans, X Huang, E Gauthier, C Fesl, AC Dueck, A DeMichele, M Gnant 11/20/2023 Breast cancer research and treatment
C Taylor, J Meisel, AJ Foreman, C Russell, D Bandyopadhyay, X Deng, L Floyd, A Zelnak, H Bear, R O'Regan 05/01/2023 Journal of vascular and interventional radiology : JVIR
N Nezami, A Behi, S Manyapu, JL Meisel, N Resnick, D Corn, JD Prologo 05/01/2023 Clinical nuclear medicine
OA Adediran, IO Lawal, S Muzahir, MA Bhave, S Friend, B Fielder, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, RJ Crowe, GA Ulaner, DM Schuster 04/01/2023 Gynecologic oncology
YL Liu, BL Manning-Geist, A Knezevic, L Deng, M Bromberg, SA Funt, JL Meisel, O Zivanovic, KL Roche, Y Sonoda, GJ Gardner, RN Grisham, RE O'Cearbhaill, WP Tew, NR Abu-Rustum, DS Chi, C Aghajanian, DR Feldman 03/01/2023 When the personal becomes political: The impact of the Dobbs decision on women with cancer.
Cancer
JL Meisel, A Harrington, N Whaley, W Vitek, RM O'Regan 01/15/2023 Clinical nuclear medicine
IO Lawal, OA Adediran, S Muzahir, S Friend, MA Bhave, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, B Fielder, RJ Crowe, GA Ulaner, DM Schuster 01/01/2023 Cardiovascular and interventional radiology
R Wu, K Gogineni, J Meisel, S Szabo, M Thirunavu, S Friend, Z Bercu, I Sethi, N Natarajan, J Switchenko, J Levy, E Abdalla, L Weakland, K Kalinsky, N Kokabi 11/01/2022 Gynecologic oncology reports
EV Carballo, TV Pham, G Turashvili, K Hanley, KD Starbuck, JL Meisel 10/01/2022 Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.
Public health genomics
E Rose, MW Hardy, R Gates, C Stanislaw, J Meisel, KA Grinzaid 08/09/2022 Breast cancer research and treatment
TTA Nguyen, LM Postlewait, C Zhang, JL Meisel, R O'Regan, S Badve, K Kalinsky, X Li 04/01/2022 Journal of cancer education : the official journal of the American Association for Cancer Education
KA Yeager, J Bai, K Gogineni, JL Meisel, J Kweon, DW Bruner, D Waldrop-Valverde 04/01/2022 Correlates of financial toxicity in adult cancer patients and their informal caregivers.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
G Sadigh, J Switchenko, KE Weaver, D Elchoufi, J Meisel, MA Bilen, D Lawson, D Cella, B El-Rayes, R Carlos 01/01/2022 Therapeutic advances in medical oncology
C Taylor, J Meisel, K Kalinsky 01/01/2022 Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
Clinical breast cancer
E Sakach, R O'Regan, J Meisel, X Li 12/01/2021 Current problems in cancer. Case reports
R Schapiro, VM Moncayo, JL Meisel 12/01/2021 International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
KZ Hanley, IR Horowitz, A Gordon, J Meisel, N Khanna 09/01/2021 Cancer
CE Taylor, JL Meisel 08/15/2021 Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
SM Smith, K Wachter, HA Burris, RL Schilsky, DJ George, DE Peterson, ML Johnson, MJ Markham, KF Mileham, MS Beg, JC Bendell, R Dreicer, VL Keedy, RJ Kimple, MA Knoll, N LoConte, H MacKay, JL Meisel, TJ Moynihan, DA Mulrooney, TM Mulvey, O Odenike, NA Pennell, K Reeder-Hayes, C Smith, RJ Sullivan, R Uzzo 04/01/2021 Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer.
Cancer
CE Taylor, JL Meisel 03/15/2021 Clinical breast cancer
CE Escott, D Zaenger, JM Switchencko, JY Lin, M Abugideiri, CA Arciero, NT Pfister, KM Xu, JL Meisel, P Subhedar, M Torres, WJ Curran, PR Patel 12/01/2020 Pathology, research and practice
J Zhao, U Krishnamurti, C Zhang, J Meisel, Z Wei, A Suo, R Aneja, Z Li, X Li 11/01/2020 Breast cancer research and treatment
J Zhao, J Meisel, Y Guo, R Nahta, KL Hsieh, L Peng, Z Wei, R O'Regan, X Li 10/01/2020 Journal of cancer education : the official journal of the American Association for Cancer Education
BA McDaniels, RS Hianik, C Bellcross, WL Shaib, J Switchenko, MD Dixon, JL Meisel, K Gogineni, RD Pentz 10/01/2020 Optimizing the Duration of Trastuzumab: A Fresh Perspective.
Oncology (Williston Park, N.Y.)
MA Taylor, KF Byers, JL Meisel 08/12/2020 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
MJ Markham, K Wachter, N Agarwal, MM Bertagnolli, SM Chang, W Dale, CSM Diefenbach, C Rodriguez-Galindo, DJ George, TD Gilligan, RD Harvey, ML Johnson, RJ Kimple, MA Knoll, N LoConte, RG Maki, JL Meisel, JA Meyerhardt, NA Pennell, GB Rocque, MS Sabel, RL Schilsky, BJ Schneider, WD Tap, RG Uzzo, SN Westin 04/01/2020 Clinical breast cancer
JL Meisel, J Zhao, A Suo, C Zhang, Z Wei, C Taylor, R Aneja, U Krishnamurti, Z Li, R Nahta, R O'Regan, X Li 02/01/2020 Race, breast cancer, and prognosis: Where biology is queen?
Cancer
JL Meisel, RM O'Regan 09/15/2019 Breast cancer research : BCR
TA Patel, JE Ensor, SL Creamer, T Boone, AA Rodriguez, PA Niravath, JG Darcourt, JL Meisel, X Li, J Zhao, JG Kuhn, RR Rosato, W Qian, A Belcheva, MR Schwartz, VG Kaklamani, JC Chang 09/02/2019 A Big World Made Small: Using Social Media to Optimize Patient Care.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
IM Subbiah, E Hamilton, M Knoll, K Shanahan, J Meisel 01/01/2019 Breast Cancer and Heart Failure.
Heart failure clinics
Z Almuwaqqat, JL Meisel, A Barac, S Parashar 01/01/2019 Clinical breast cancer
J Meisel, C Zhang, C Neely, P Mendoza, S You, T Han, Y Liu, AA Sahin, R O'Regan, X Li 10/01/2018 Breast cancer research and treatment
X Li, Y Zhang, J Meisel, R Jiang, M Behera, L Peng 09/01/2018 Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer.
Oncology (Williston Park, N.Y.)
C Arciero, P Thompson, JL Meisel, CE Taylor, MA Torres, WC Wood 08/15/2018 Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
JL Meisel, VA Venur, M Gnant, L Carey 05/23/2018 Clinical cancer research : an official journal of the American Association for Cancer Research
B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, I García-Murillas, C Fribbens, R Cutts, LG Martelotto, CKY Ng, RS Lim, P Selenica, S Piscuoglio, C Aghajanian, L Norton, R Murali, DM Hyman, L Borsu, ME Arcila, J Konner, JS Reis-Filho, RA Greenberg, ME Robson, NC Turner 11/01/2017 Management of Breast Cancer Therapy-Related Sexual Dysfunction.
Oncology (Williston Park, N.Y.)
CE Taylor, JL Meisel 10/15/2017 Gynecologic oncology reports
VM Alexander, J Meisel, S O'Brien, N Khanna 02/01/2017 For Our Patients, for Ourselves: The Value of Personal Reflection in Oncology.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
L Schapira, JL Meisel, R Srivastava 01/01/2017 Breast cancer research and treatment
X Li, J Yang, L Peng, AA Sahin, L Huo, KC Ward, R O'Regan, MA Torres, JL Meisel 01/01/2017 Prevention and Screening in Hereditary Breast and Ovarian Cancer.
Oncology (Williston Park, N.Y.)
SB Zeichner, C Stanislaw, JL Meisel 10/15/2016 American journal of clinical pathology
X Li, CS Wetherilt, U Krishnamurti, J Yang, Y Ma, TM Styblo, JL Meisel, L Peng, MT Siddiqui, C Cohen, R Aneja 10/01/2016 Development of a risk stratification system to guide treatment for female germ cell tumors.
Gynecologic oncology
JL Meisel, KM Woo, N Sudarsan, J Eng, S Patil, EP Jacobsen, R Murali, GJ Gardner, GJ Bosl, C Aghajanian, DR Feldman 09/01/2015 Awards
Dr. Meisel has received several teaching awards, including the Resident Mentor Award and Notable Teaching Award at Brigham and Women's Hospital. She currently serves as a core faculty member for the internal medicine residency at Emory University School of Medicine where she enjoys mentoring students and residents in the clinic and in their research.
She received an American Society for Clinical Oncology (ASCO) Young Investigator Award in 2014 for her research evaluating the use of circulating tumor DNA to detect platinum resistance in patients with BRCA mutations and recurrent ovarian cancer.
She has been consistently listed in Atlanta Magazine's annual "Top Doctors" issue.
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.9 Provider showed concern 4.9 Provider explained things clearly 4.9 Provider discussed treatment options 4.9 Provider included you in decisions 4.9 Likelihood of recommending this provider